GlaxoSmithKline | GSK

Stock Price
2,213.00
Daily Change
-13.00 -0.58%
Monthly
22.64%
Yearly
52.36%
Q1 Forecast
2,168.74



Peers Price Chg Day Year Date
AbbVie 224.81 0.46 0.21% 11.25% Feb/20
Alcon AG 64.28 0.36 0.56% -20.88% Feb/20
Almirall 13.42 -0.28 -2.04% 47.23% Feb/20
Amgen 374.75 -0.75 -0.20% 23.68% Feb/20
argenx SE 722.40 4.80 0.67% 16.67% Feb/20
AstraZeneca 15,270.00 -20.00 -0.13% 29.71% Feb/21
Bayer 43.68 -1.90 -4.16% 96.09% Feb/21
Biogen 192.03 -0.05 -0.03% 36.54% Feb/20
Bristol-Myers Squibb 60.66 0.36 0.60% 8.65% Feb/20
Fresenius Medical Care 41.17 0.48 1.18% -7.71% Feb/21

Indexes Price Day Year Date
GB100 10687 59.85 0.56% 23.41% Feb/20
EU600 631 5.23 0.84% 13.85% Feb/20

GlaxoSmithKline traded at 2,213.00 this Saturday February 21st, decreasing 13.00 or 0.58 percent since the previous trading session. Looking back, over the last four weeks, GlaxoSmithKline lost 22.64 percent. Over the last 12 months, its price rose by 52.36 percent. Looking ahead, we forecast GlaxoSmithKline to be priced at 2,168.74 by the end of this quarter and at 2,041.20 in one year, according to Trading Economics global macro models projections and analysts expectations.

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.



News Stream
GlaxoSmithKline Stock Price Hits 21-1/2-year High
GlaxoSmithKline shares increased to 2221.00 GBp, the highest since July 2004. Over the past 4 weeks, GlaxoSmithKline gained 21.97%, and in the last 12 months, it increased 53.5%.
2026-02-17
GlaxoSmithKline Stock Price Hits 21-1/2-year High
GlaxoSmithKline shares increased to 2062.00 GBp, the highest since July 2004. Over the past 4 weeks, GlaxoSmithKline gained 13.1%, and in the last 12 months, it increased 38.65%.
2026-02-04
GlaxoSmithKline Stock Price Hits 6-week High
GlaxoSmithKline shares increased to 1910.00 GBp, the highest since December 2025. Over the past 4 weeks, GlaxoSmithKline gained 4.86%, and in the last 12 months, it increased 36.5%.
2026-02-02